Fig. 6.
– Correlation between the changes of FEV1 and those of FVC after salbutamol 400 μg in the entire group, in subjects without concomitant obstructive lung diseases (No OLD), in COPD and in asthma.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.